Tick-Transmitted Diseases in Dogs: Anaplasmosis, Ehrlichiosis, and Lyme Disease

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-06-06

Key Takeaways

• Anaplasmosis, ehrlichiosis, and Lyme disease are significant tick-borne bacterial infections in dogs, transmitted by Ixodes, Rhipicephalus, and Amblyomma ticks, with geographic distribution dictated by vector range and reservoir hosts.
• Anaplasma and Ehrlichia species are obligate intracellular bacteria infecting neutrophils, platelets, or monocytes/macrophages, while Borrelia burgdorferi is a spirochete that disseminates through connective tissues.
• Clinical signs range from subclinical to severe, including fever, lethargy, lameness, lymphadenopathy, and characteristic thrombocytopenia in anaplasmosis and ehrlichiosis, while Lyme disease can manifest as lameness or, rarely, severe glomerulonephritis (Lyme nephritis).
• Diagnosis relies on a combination of serology (ELISA, IFA) detecting antibodies and molecular methods (PCR, real-time PCR) for pathogen DNA, supported by hematologic findings like thrombocytopenia.
• Doxycycline is the primary therapeutic agent for anaplasmosis and ehrlichiosis, with treatment duration varying by disease phase; doxycycline is also the first-line treatment for Lyme disease, and consistent acaricide use is crucial for prevention.
• Prevention strategies focus on consistent application of effective acaricides, with available vaccines for Lyme disease having debated efficacy and no current vaccines for canine anaplasmosis or ehrlichiosis.

Introduction

Tick-transmitted diseases represent a significant and growing burden in canine medicine worldwide [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Among the most clinically relevant are anaplasmosis (caused by Anaplasma phagocytophilum and Anaplasma platys), ehrlichiosis (caused primarily by Ehrlichia canis, Ehrlichia chaffeensis, and Ehrlichia ewingii), and Lyme disease (caused by Borrelia burgdorferi sensu stricto) [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>]. These obligate intracellular bacteria and spirochetes are transmitted by ixodid ticks of the genera Ixodes, Rhipicephalus, and Amblyomma [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. The geographic distribution of each pathogen is largely determined by the range of its competent tick vector and the presence of suitable reservoir hosts [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>]. Understanding the biological, clinical, and diagnostic nuances of these infections is essential for veterinary practitioners in endemic regions [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. This article provides a detailed review of the three major dog tick transmitted diseases with emphasis on molecular pathogenesis, diagnostic algorithms, and evidence-based management.

Epidemiology and Vector Ecology

The epidemiology of canine anaplasmosis, ehrlichiosis, and Lyme disease reflects complex interactions between tick vectors, vertebrate reservoirs, and environmental factors [<a href="#ref-10">10</a>, <a href="#ref-13">13</a>]. Anaplasma phagocytophilum is transmitted by Ixodes spp. ticks and has been documented in North America, Europe, and Asia [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. Seroprevalence studies in dogs from the United States have identified associations with geographic region, season, and tick exposure [<a href="#ref-10">10</a>]. Anaplasma platys, the agent of cyclic thrombocytopenia, is transmitted by Rhipicephalus sanguineus and has a global distribution in tropical and subtropical regions [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>].

Ehrlichia canis is also vectored by R. sanguineus and is endemic in many parts of the Americas, Africa, Asia, and southern Europe [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-19">19</a>, <a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Ehrlichia chaffeensis and E. ewingii are primarily transmitted by Amblyomma americanum in the United States [<a href="#ref-22">22</a>, <a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Molecular surveys using multiplex PCR have demonstrated co-infections with multiple tick-borne pathogens in individual dogs, complicating clinical diagnosis [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>, <a href="#ref-17">17</a>].

Borrelia burgdorferi sensu lato is maintained in enzootic cycles involving Ixodes ticks and small mammal reservoirs [<a href="#ref-25">25</a>, <a href="#ref-26">26</a>]. Canine seroprevalence is highest in regions where Ixodes scapularis and Ixodes pacificus are established, including the northeastern, mid-Atlantic, and upper Midwestern United States, as well as parts of Europe and Asia [<a href="#ref-3">3</a>, <a href="#ref-21">21</a>, <a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. In Australia, canine sentinel studies have not confirmed endemic Lyme borreliosis, suggesting the absence of competent enzootic transmission [<a href="#ref-26">26</a>].

Table 1 summarizes the primary pathogens, vectors, and geographic distributions.

Table 1. Major tick-transmitted pathogens of dogs: vectors and distribution.

Pathogen Biology and Life Cycle

All three disease agents are transmitted during tick feeding. Anaplasma and Ehrlichia species are obligate intracellular Gram-negative bacteria that replicate within membrane-bound vacuoles in host cells [<a href="#ref-4">4</a>, <a href="#ref-32">32</a>]. A. phagocytophilum preferentially infects neutrophils, while A. platys targets platelets [<a href="#ref-14">14</a>]. E. canis infects monocytes and macrophages, and E. chaffeensis also targets mononuclear phagocytes [<a href="#ref-22">22</a>, <a href="#ref-29">29</a>, <a href="#ref-30">30</a>]. E. ewingii infects granulocytes [<a href="#ref-24">24</a>]. The genomes of these bacteria are reduced, reflecting their dependence on host cell machinery [<a href="#ref-32">32</a>].

Borrelia burgdorferi is a motile spirochete that resides in the tick midgut and migrates to the salivary glands during feeding [<a href="#ref-31">31</a>]. In the canine host, B. burgdorferi disseminates through connective tissues and can evade immune clearance through antigenic variation [<a href="#ref-31">31</a>, <a href="#ref-33">33</a>].

Persistence in the vertebrate host is a hallmark of these infections. E. chaffeensis employs multiple genes for immune evasion and persistent infection, as demonstrated by random mutagenesis studies [<a href="#ref-30">30</a>]. Genes critical for persistence in the vertebrate host are not necessarily required for growth in the tick vector, indicating distinct selective pressures [<a href="#ref-22">22</a>]. Live attenuated vaccines using targeted gene deletions have shown promise in inducing protective CD4+ T cell responses in dogs [<a href="#ref-29">29</a>, <a href="#ref-34">34</a>]. Similarly, outer membrane protein (OMP-1B) and type IV secretion system (VirB2-4) vaccines have been evaluated for protection against tick-transmitted E. chaffeensis challenge [<a href="#ref-23">23</a>].

Clinical Signs

Clinical manifestations of tick-transmitted diseases in dogs range from subclinical infection to severe, life-threatening illness [<a href="#ref-12">12</a>]. The incubation period varies by pathogen and dose.

Anaplasmosis. Acute A. phagocytophilum infection typically presents with fever, lethargy, anorexia, and lameness due to polyarthritis [<a href="#ref-14">14</a>, <a href="#ref-15">15</a>]. Thrombocytopenia is a consistent hematologic finding [<a href="#ref-14">14</a>]. A. platys infection causes cyclic thrombocytopenia, with platelet counts dropping every 10-14 days; clinical signs are often mild but can include petechiae and epistaxis [<a href="#ref-17">17</a>, <a href="#ref-18">18</a>].

Ehrlichiosis. Canine monocytic ehrlichiosis (CME) caused by E. canis progresses through acute, subclinical, and chronic phases [<a href="#ref-12">12</a>]. The acute phase (1-4 weeks post-infection) features fever, lymphadenomegaly, and thrombocytopenia. The subclinical phase may last months to years. Chronic CME is characterized by pancytopenia, bleeding diathesis, and secondary infections [<a href="#ref-12">12</a>]. E. chaffeensis and E. ewingii infections in dogs are less well characterized but can cause fever, polyarthritis, and thrombocytopenia [<a href="#ref-23">23</a>, <a href="#ref-24">24</a>].

Lyme disease. Most dogs infected with B. burgdorferi remain asymptomatic [<a href="#ref-33">33</a>]. A subset develops acute lameness, fever, and lymphadenopathy. A severe immune-mediated glomerulonephritis, termed Lyme nephritis, has been described in certain breeds (e.g., Labrador Retrievers, Rottweilers) and carries a poor prognosis [<a href="#ref-31">31</a>, <a href="#ref-33">33</a>]. Neurologic signs are rare in dogs compared to humans [<a href="#ref-27">27</a>].

Diagnostics

Accurate diagnosis relies on a combination of serologic and molecular methods, supported by hematologic and biochemical findings [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>, <a href="#ref-28">28</a>].

Serology. Detection of antibodies against A. phagocytophilum, E. canis, and B. burgdorferi is commonly performed using commercial ELISA kits that incorporate synthetic peptides such as the C6 peptide for B. burgdorferi [<a href="#ref-3">3</a>, <a href="#ref-21">21</a>, <a href="#ref-31">31</a>]. Indirect immunofluorescence assays (IFA) are also used but require paired acute and convalescent samples for confirmation [<a href="#ref-27">27</a>, <a href="#ref-28">28</a>]. Seroprevalence surveys have provided valuable epidemiologic data [<a href="#ref-10">10</a>, <a href="#ref-13">13</a>].

Molecular detection. PCR assays targeting species-specific genes (e.g., 16S rRNA, groEL, p28 OMP genes) offer high sensitivity and specificity for active infection [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>, <a href="#ref-15">15</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>]. Multiplex PCR panels can simultaneously detect Anaplasma, Ehrlichia, and Borrelia species [<a href="#ref-2">2</a>]. Real-time PCR is increasingly used in reference laboratories.

Hematology and biochemistry. Thrombocytopenia is a hallmark of both anaplasmosis and ehrlichiosis [<a href="#ref-12">12</a>, <a href="#ref-14">14</a>]. Pancytopenia suggests chronic E. canis infection. Proteinuria and azotemia may indicate Lyme nephritis [<a href="#ref-33">33</a>].

Table 2 summarizes diagnostic approaches.

Table 2. Diagnostic methods for tick-transmitted diseases in dogs.

Treatment

Doxycycline is the cornerstone of therapy for anaplasmosis and ehrlichiosis [<a href="#ref-6">6</a>, <a href="#ref-12">12</a>]. A standard course of 10-14 days is recommended for acute anaplasmosis; for ehrlichiosis, treatment may extend to 28 days or longer in chronic cases [<a href="#ref-12">12</a>]. Tetracycline antibiotics are also effective [<a href="#ref-6">6</a>]. Clinical improvement is usually rapid, but hematologic recovery may take weeks.

For Lyme disease, doxycycline (10 mg/kg q24h for 30 days) is the first-line agent [<a href="#ref-33">33</a>]. Supportive care including fluid therapy and nephroprotective measures is indicated for dogs with protein-losing nephropathy [<a href="#ref-33">33</a>]. The use of acaricides to prevent tick attachment is critical in endemic areas.

Prevention and Control

Prevention of tick-transmitted diseases relies primarily on consistent use of acaricides [<a href="#ref-1">1</a>]. Topical spot-on formulations, collars, and oral isoxazoline compounds have demonstrated efficacy in reducing tick infestation and pathogen transmission. Integrated tick management includes environmental control and avoidance of tick habitats.

Vaccines for canine Lyme disease are available in some regions, but their efficacy is debated [<a href="#ref-33">33</a>]. Experimental vaccines for E. chaffeensis using attenuated mutants or subunit antigens have shown promise in laboratory settings but are not yet commercially available [<a href="#ref-23">23</a>, <a href="#ref-29">29</a>, <a href="#ref-34">34</a>]. No vaccines are currently licensed for canine anaplasmosis or ehrlichiosis.

The following Mermaid diagram outlines a diagnostic decision tree for a dog presenting with suspected tick-transmitted disease.

flowchart TD
 A["Clinical suspicion: fever, lameness, thrombocytopenia"] --> B{"Point-of-care ELISA"}
 B -->|"Positive for Anaplasma/Ehrlichia"| C["PCR confirmation and species identification"]
 B -->|"Positive for B. burgdorferi C6"| D["Urinalysis for proteinuria"]
 B -->|"Negative"| E["Consider other diagnoses: babesiosis, immune-mediated disease"]
 C --> F["Initiate doxycycline therapy"]
 D --> G["If proteinuric: manage Lyme nephritis"]
 F --> H["Monitor clinical and hematologic response"]
 G --> H

Related Clinical & Scientific Guides

• Tick-Borne Diseases in Dogs: Pathogens, Clinical Signs, Diagnosis, and Prevention
• Toxoplasmosis in Cats and the Risk of Brain Infection in Humans
• Dog Heartworm and Tick-Borne Disease Prevention

References